Astena Group announces that its subsidiaries Spera Pharma and Spera Nexus will exhibit at 'CPHI Japan 2026', to be held in 2026. This exhibition is an international event gathering the latest technologies and products in the pharmaceutical and healthcare industries. Astena Group transitioned to a holding company structure on June 1, 2021, and aims for sustainable growth through ESG management and investment in new businesses, with five core businesses: fine chemicals, pharmaceuticals, HBC food, chemical products, and social impact.
FACT BOX
- Source: PR TIMES
- Category: Event